[1]
|
Hu, K., Ding, P., Wu, Y., et al. (2019) Global Patterns and Trends in the Breast Cancer Incidence and Mortality According to Sociodemographic Indices: An Observational Study Based on the Global Burden of Diseases. BMJ Open, 9, e28461. https://doi.org/10.1136/bmjopen-2018-028461
|
[2]
|
Ferlay, J., Colombet, M., Soerjomataram, I., et al. (2021) Cancer Statistics for the Year 2020: An Overview. International Journal of Cancer, 149, 778-789. https://doi.org/10.1002/ijc.33588
|
[3]
|
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[4]
|
Widschwendter, P., Friedl, T.W., Schwentner, L., et al. (2015) The Influence of Obesity on Survival in Early, High-Risk Breast Cancer: Results from the Randomized SUCCESS A Trial. Breast Cancer Research, 17, 129.
https://doi.org/10.1186/s13058-015-0639-3
|
[5]
|
He, D.E., Bai, J.W., Liu, J., et al. (2015) Clinicopathological Characteristics and Prognosis of Breast Cancer Patients with Type 2 Diabetes Mellitus. Molecular and Clinical Oncology, 3, 607-612. https://doi.org/10.3892/mco.2015.522
|
[6]
|
Lega, I.C., Austin, P.C., Fischer, H.D., et al. (2018) The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study. Diabetes Care, 41, 755-761. https://doi.org/10.2337/dc17-2012
|
[7]
|
乔晓娟, 李昊昌, 李云霞, 等. 内蒙古地区女性乳腺癌与2型糖尿病关系的回顾性分析[J]. 中国医药科学, 2013, 3(22): 161-162.
|
[8]
|
朱晴晴. 2型糖尿病对乳腺癌患者病情发展及淋巴结转移的影响[J]. 航空航天医学杂志, 2021, 32(4): 408-409.
|
[9]
|
Smiley, D. and Umpierrez, G.E. (2010) Management of Hyperglycemia in Hospitalized Patients. Annals of the New York Academy of Sciences, 1212, 1-11. https://doi.org/10.1111/j.1749-6632.2010.05805.x
|
[10]
|
Ziech, D., Franco, R., Georgakilas, A.G., et al. (2010) The Role of Reactive Oxygen Species and Oxidative Stress in Environmental Carcinogenesis and Biomarker Development. Chemico-Biological Interactions, 188, 334-339.
https://doi.org/10.1016/j.cbi.2010.07.010
|
[11]
|
Kellenberger, L.D., Bruin, J.E., Greenaway, J., et al. (2010) The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer. Journal of Oncology, 2010, Article ID: 514310. https://doi.org/10.1155/2010/514310
|
[12]
|
Wang, Y., Zhu, Y.D., Gui, Q., et al. (2014) Glucagon-Induced Angiogenesis and Tumor Growth through the HIF-1-VEGF-Dependent Pathway in Hyperglycemic Nude Mice. Genetics and Molecular Research, 13, 7173-7183.
https://doi.org/10.4238/2014.September.5.3
|
[13]
|
Lopez, R., Arumugam, A., Joseph, R., et al. (2013) Hyperglycemia Enhances the Proliferation of Non-Tumorigenic and Malignant Mammary Epithelial Cells through Increased leptin/IGF1R Signaling and Activation of AKT/mTOR. PLoS ONE, 8, e79708. https://doi.org/10.1371/journal.pone.0079708
|
[14]
|
Alisson-Silva, F., Freire-de-Lima, L., Donadio, J.L., et al. (2013) Increase of O-Glycosylated Oncofetal Fibronectin in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Epithelial Cells. PLoS ONE, 8, e60471.
https://doi.org/10.1371/journal.pone.0060471
|
[15]
|
Flores-López, L.A., Martínez-Hernández, M.G., Viedma-Rodríguez, R., et al. (2016) High Glucose and Insulin Enhance uPA Expression, ROS Formation and Invasiveness in Breast Cancer-Derived Cells. Cellular Oncology, 39, 365-378. https://doi.org/10.1007/s13402-016-0282-8
|
[16]
|
Viedma-Rodríguez, R., Martínez-Hernández, M.G., Flores-López, L.A., et al. (2018) Epsilon-Aminocaproic Acid Prevents High Glucose and Insulin Induced-Invasiveness in MDA-MB-231 Breast Cancer Cells, Modulating the Plasminogen Activator System. Molecular and Cellular Biochemistry, 437, 65-80. https://doi.org/10.1007/s11010-017-3096-8
|
[17]
|
Zielinska, H.A., Holly, J.M.P., Bahl, A., et al. (2018) Inhibition of FASN and ERα Signalling during Hyperglycaemia-Induced Matrix-Specific EMT Promotes Breast Cancer Cell Invasion via a Caveolin-1-Dependent Mechanism. Cancer Letters, 419, 187-202. https://doi.org/10.1016/j.canlet.2018.01.028
|
[18]
|
Adham, S.A., Al, R.H., Habib, S., et al. (2014) Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules. PLoS ONE, 9, e113103. https://doi.org/10.1371/journal.pone.0113103
|
[19]
|
Gajeton, J., Krukovets, I., Muppala, S., et al. (2021) Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer. Cancers, 13, 1346. https://doi.org/10.3390/cancers13061346
|
[20]
|
Saltiel, A.R., Kahn, C.R. (2001) Insulin Signalling and the Regulation of Glucose and Lipid Metabolism. Nature, 414, 799-806. https://doi.org/10.1038/414799a
|
[21]
|
Engelman, J.A., Luo, J. and Cantley, L.C. (2006) The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism. Nature Reviews Genetics, 7, 606-619. https://doi.org/10.1038/nrg1879
|
[22]
|
Zhang, A.M.Y., Wellberg, E.A., Kopp, J.L., et al. (2021) Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes & Metabolism Journal, 45, 285-311. https://doi.org/10.4093/dmj.2020.0250
|
[23]
|
LeRoith, D. and Roberts, C.T. (2003) The Insulin-Like Growth Factor System and Cancer. Cancer Letters, 195, 127-137. https://doi.org/10.1016/S0304-3835(03)00159-9
|
[24]
|
Cascio, S., Bartella, V., Auriemma, A., et al. (2008) Mechanism of Leptin Expression in Breast Cancer Cells: Role of Hypoxia-Inducible Factor-1. Oncogene, 27, 540-547. https://doi.org/10.1038/sj.onc.1210660
|
[25]
|
Cordero-Franco, H.F., Salinas-Martínez, A.M., Abundis, A., et al. (2014) The Effect of Insulin Resistance on Breast Cancer Risk in Latinas of Mexican Origin. Metabolic Syndrome and Related Disorders, 12, 477-483.
https://doi.org/10.1089/met.2014.0071
|
[26]
|
Murphy, N., Knuppel, A., Papadimitriou, N., et al. (2020) Insulin-Like Growth Factor-1, Insulin-Like Growth Factor-Binding Protein-3, and Breast Cancer Risk: Observational and Mendelian Randomization Analyses with ~430,000 Women. Annals of Oncology, 31, 641-649. https://doi.org/10.1016/j.annonc.2020.01.066
|
[27]
|
De, Vincenzo, A., Belli, S., Franco, P., et al. (2019) Paracrine Recruitment and Activation of Fibroblasts by c-Myc Expressing Breast Epithelial Cells through the IGFs/IGF-1R Axis. International Journal of Cancer, 145, 2827-2839.
https://doi.org/10.1002/ijc.32613
|
[28]
|
Bates, P., Fisher, R., Ward, A., et al. (1995) Mammary Cancer in Transgenic Mice Expressing Insulin-Like Growth Factor II (IGF-II). British Journal of Cancer, 72, 1189-1193. https://doi.org/10.1038/bjc.1995.484
|
[29]
|
Tworoger, S.S., Eliassen, A.H., Kelesidis, T., et al. (2007) Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer. The Journal of Clinical Endocrinology & Metabolism, 92, 1510-1516.
https://doi.org/10.1210/jc.2006-1975
|
[30]
|
Taliaferro-Smith, L., Nagalingam, A., Knight, B.B., et al. (2013) Integral Role of PTP1B in Adiponectin-Mediated Inhibition of Oncogenic Actions of Leptin in Breast Carcinogenesis. Neoplasia, 15, 11-23.
https://doi.org/10.1593/neo.121502
|
[31]
|
Dos, S.E., Benaitreau, D., Dieudonne, M.N., et al. (2008) Adiponectin Mediates an Antiproliferative Response in Human MDA-MB 231 Breast Cancer Cells. Oncology Reports, 20, 971-977.
|
[32]
|
Taliaferro-Smith, L., Nagalingam, A., Zhong, D., et al. (2009) LKB1 Is Required for Adiponectin-Mediated Modulation of AMPK-S6K Axis and Inhibition of Migration and Invasion of Breast Cancer Cells. Oncogene, 28, 2621-2633.
https://doi.org/10.1038/onc.2009.129
|
[33]
|
沈丽, 段卫明, 陶敏. 乳腺癌与糖尿病关联研究的新进展[J]. 现代仪器与医疗, 2014, 20(1): 17-21.
|
[34]
|
Pham, D. and Park, P. (2022) Adiponectin Triggers Breast Cancer Cell Death via Fatty Acid Metabolic Reprogramming. Journal of Experimental & Clinical Cancer Research, 41, Article No. 9.
https://doi.org/10.1186/s13046-021-02223-y
|
[35]
|
Pan, H., Deng, L., Cui, J., et al. (2018) Association between Serum Leptin Levels and Breast Cancer Risk. Medicine, 97, e11345. https://doi.org/10.1097/MD.0000000000011345
|
[36]
|
Niu, J., Jiang, L., Guo, W., et al. (2013) The Association between Leptin Level and Breast Cancer: A Meta-Analysis. PLoS ONE, 8, e67349. https://doi.org/10.1371/journal.pone.0067349
|
[37]
|
And, Ã.S., Barone, I., Giordano, C., et al. (2014) The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression. Frontiers in Oncology, 4, Article No. 340.
https://doi.org/10.3389/fonc.2014.00340
|
[38]
|
Wu, L., Chen, G., Liu, W., et al. (2017) Intramuscular Injection of Exogenous Leptin Induces Adiposity, Glucose Intolerance and Fatty Liver by Repressing the JAK2-STAT3/PI3K Pathway in a Rat Model. General and Comparative Endocrinology, 252, 88-96. https://doi.org/10.1016/j.ygcen.2017.02.012
|
[39]
|
Mahbouli, S., Der Vartanian, A., Ortega, S., et al. (2017) Leptin Induces ROS via NOX5 in Healthy and Neoplastic Mammary Epithelial Cells. Oncology Reports, 38, 3254-3264. https://doi.org/10.3892/or.2017.6009
|
[40]
|
Nepal, S., Jin, K.M., Hong, J.T., et al. (2015) Autophagy Induction by Leptin Contributes to Suppression of Apoptosis in Cancer Cells and Xenograft Model: Involvement of p53/FoxO3A Axis. Oncotarget, 6, 7166-7181.
https://doi.org/10.18632/oncotarget.3347
|
[41]
|
Li, K., Wei, L., Huang, Y., et al. (2016) Leptin Promotes Breast Cancer Cell Migration and Invasion via IL-18 Expression and Secretion. International Journal of Oncology, 48, 2479-2487. https://doi.org/10.3892/ijo.2016.3483
|
[42]
|
Dalamaga, M., Sotiropoulos, G., Karmaniolas, K., et al. (2013) Serum Resistin: A Biomarker of Breast Cancer in Postmenopausal Women? Association with Clinicopathological Characteristics, Tumor Markers, Inflammatory and Metabolic Parameters. Clinical Biochemistry, 46, 584-590. https://doi.org/10.1016/j.clinbiochem.2013.01.001
|
[43]
|
Lee, Y., Chen, Y., Wu, C., et al. (2012) Resistin Expression in Breast Cancer Tissue as a Marker of Prognosis and Hormone Therapy Stratification. Gynecologic Oncology, 125, 742-750. https://doi.org/10.1016/j.ygyno.2012.02.032
|
[44]
|
Wang, C., Wang, P., Hsieh, Y., et al. (2018) Resistin Facilitates Breast Cancer Progression via TLR4-Mediated Induction of Mesenchymal Phenotypes and Stemness Properties. Oncogene, 37, 589-600.
https://doi.org/10.1038/onc.2017.357
|
[45]
|
Deshmukh, S.K., Srivastava, S.K., Bhardwaj, A., et al. (2015) Resistin and Interleukin-6 Exhibit Racially-Disparate Expression in Breast Cancer Patients, Display Molecular Association and Promote Growth and Aggressiveness of Tumor Cells through STAT3 Activation. Oncotarget, 6, 11231-11241. https://doi.org/10.18632/oncotarget.3591
|
[46]
|
Lee, J.O., Kim, N., Lee, H.J., et al. (2016) Resistin, a Fat-Derived Secretory Factor, Promotes Metastasis of MDA-MB-231 Human Breast Cancer Cells through ERM Activation. Scientific Reports, 6, Article No. 18923.
https://doi.org/10.1038/srep18923
|
[47]
|
Yu, H., Lee, H., Herrmann, A., et al. (2014) Revisiting STAT3 Signalling in Cancer: New and Unexpected Biological Functions. Nature Reviews Cancer, 14, 736-746. https://doi.org/10.1038/nrc3818
|
[48]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545.
https://doi.org/10.1016/S0140-6736(00)04046-0
|
[49]
|
Kim, G., Ouzounova, M., Quraishi, A.A., et al. (2015) SOCS3-Mediated Regulation of Inflammatory Cytokines in PTEN and p53 Inactivated Triple Negative Breast Cancer Model. Oncogene, 34, 671-680.
https://doi.org/10.1038/onc.2014.4
|
[50]
|
Chang, S. and Yang, W.V. (2016) Hyperglycemia, Tumorigenesis, and Chronic Inflammation. Critical Reviews in Oncology/Hematology, 108, 146-153. https://doi.org/10.1016/j.critrevonc.2016.11.003
|